tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apogee Therapeutics’ Promising Update on Long-term APG777 Study for Atopic Dermatitis
PremiumCompany AnnouncementsApogee Therapeutics’ Promising Update on Long-term APG777 Study for Atopic Dermatitis
12d ago
Mizuho Securities Recommends Buy for Apogee Therapeutics Due to Promising APG777 Efficacy in Th2 Inflammatory Diseases
Premium
Ratings
Mizuho Securities Recommends Buy for Apogee Therapeutics Due to Promising APG777 Efficacy in Th2 Inflammatory Diseases
19d ago
Apogee Therapeutics initiated with an Outperform at Mizuho
Premium
The Fly
Apogee Therapeutics initiated with an Outperform at Mizuho
19d ago
Apogee Therapeutics price target lowered to $82 from $87 at BofA
PremiumThe FlyApogee Therapeutics price target lowered to $82 from $87 at BofA
1M ago
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
Premium
The Fly
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
1M ago
Closing Bell Movers: Costco nudges higher after September sales
Premium
The Fly
Closing Bell Movers: Costco nudges higher after September sales
1M ago
3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts
2M ago
Apogee Therapeutics price target raised to $87 from $78 at BofA
Premium
The Fly
Apogee Therapeutics price target raised to $87 from $78 at BofA
2M ago
Promising Prospects for Apogee Therapeutics: Buy Rating Backed by Strong Trial Results and Financial Health
Premium
Ratings
Promising Prospects for Apogee Therapeutics: Buy Rating Backed by Strong Trial Results and Financial Health
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100